![Bernd Hoppe](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Bernd Hoppe
Director/Board Member at Oxalosis & Hyperoxaluria Foundation
Bernd Hoppe active positions
Companies | Position | Start | End |
---|---|---|---|
Oxalosis & Hyperoxaluria Foundation
![]() Oxalosis & Hyperoxaluria Foundation Medical/Nursing ServicesHealth Services The Oxalosis & Hyperoxaluria Foundation is dedicated to eradicating all forms of hyperoxaluria disease forever. The non-profit company is based in New York, NY. The company's vision is a world without hyperoxaluria, and they are committed to improving the daily lives of people with this condition. | Director/Board Member | - | - |
Career history of Bernd Hoppe
Former positions of Bernd Hoppe
Companies | Position | Start | End |
---|---|---|---|
DICERNA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2019-06-30 | - |
Statistics
International
United States | 3 |
Operational
Chief Tech/Sci/R&D Officer | 1 |
Director/Board Member | 1 |
Sectoral
Health Technology | 2 |
Health Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
Dicerna Pharmaceuticals, Inc.
![]() Dicerna Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dicerna Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in discovering, developing and commercializing medicines that are designed to leverage ribonucleic acid interference (RNAi) to selectively silence genes that cause or contribute to disease. The firm uses its proprietary GalXC RNAi technology platform to build a pipeline in these therapeutic areas. The company was founded by Douglas M. Fambrough III, Mark A. Behlke, Roberto Guerciolini, James Craig Jenson, and John J. Rossi in October 2006 and is headquartered in Lexington, MA. | Health Technology |
Oxalosis & Hyperoxaluria Foundation
![]() Oxalosis & Hyperoxaluria Foundation Medical/Nursing ServicesHealth Services The Oxalosis & Hyperoxaluria Foundation is dedicated to eradicating all forms of hyperoxaluria disease forever. The non-profit company is based in New York, NY. The company's vision is a world without hyperoxaluria, and they are committed to improving the daily lives of people with this condition. | Health Services |
- Stock Market
- Insiders
- Bernd Hoppe
- Experience